Literature DB >> 19757149

Evaluation of vascular reactivity of young male hypogonadotrophic hypogonadism patients.

Ferhat Deniz1, Necip Ermiş, Alper Kepez, Bariş Türk, Murat Akkoyunlu, Batuhan Kara, Mustafa Kutlu.   

Abstract

We aimed to study the vascular reactivity of young male hypogonadal hypogonadism patients without any cardiovascular risk factors and compare these findings with the ones of age-matched healthy controls. Study population consisted of 26 young male hypogonadotrophic hypogonadism patients (20.9 +/- 1.3 years) and 25 age-matched healthy male controls (21.8 +/- 2.9 years, P = NS). In addition to detailed hormonal analysis, each subject underwent ultrasound study of right brachial artery. Vessel diameter was measured at rest, during reactive hyperemia [endothelium-dependent flow-mediated vasodilation (FMD)] and after sublingual nitroglycerin administration (endothelium-independent vasodilation). Both flow-mediated and endothelium-independent sublingual nitroglycerin mediated dilatation values of patients were higher compared to controls (12.98 +/- 10.76% vs. 7.92 +/- 1.96%, P = 0.003 and 21.44 +/- 10.36% vs. 14.72 +/- 3.57%, P = 0.023, respectively). Linear regression analysis revealed that only serum HDL levels (relative risk 2.94, 95% CI 0.12-0.66, P = 0.006) and baseline vessel diameter (relative risk -2.77, 95% CI -17.73 to -2.70, P = 0.009) were found to be independently associated with FMD values. Endogenous male sex hormones seem to exert negative effects on vascular reactivity parameters and much of their effects are indirect that is by the way of alteration on lipid profile.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19757149     DOI: 10.1007/s10554-009-9505-7

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  23 in total

Review 1.  Sex hormones and coronary disease: a review of the clinical studies.

Authors:  M F Kalin; B Zumoff
Journal:  Steroids       Date:  1990-08       Impact factor: 2.668

2.  Androgenic anabolic steroids and arterial structure and function in male bodybuilders.

Authors:  M A Sader; K A Griffiths; R J McCredie; D J Handelsman; D S Celermajer
Journal:  J Am Coll Cardiol       Date:  2001-01       Impact factor: 24.094

3.  Vascular reactivity in hypogonadal men is reduced by androgen substitution.

Authors:  Michael Zitzmann; Maik Brune; Eberhard Nieschlag
Journal:  J Clin Endocrinol Metab       Date:  2002-11       Impact factor: 5.958

4.  Contrasting effects of testosterone and stanozolol on serum lipoprotein levels.

Authors:  P D Thompson; E M Cullinane; S P Sady; C Chenevert; A L Saritelli; M A Sady; P N Herbert
Journal:  JAMA       Date:  1989-02-24       Impact factor: 56.272

5.  Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits.

Authors:  P Alexandersen; J Haarbo; I Byrjalsen; H Lawaetz; C Christiansen
Journal:  Circ Res       Date:  1999-04-16       Impact factor: 17.367

6.  Premenopausal social status and hormone exposure predict postmenopausal atherosclerosis in female monkeys.

Authors:  J R Kaplan; S B Manuck; M S Anthony; T B Clarkson
Journal:  Obstet Gynecol       Date:  2002-03       Impact factor: 7.661

Review 7.  Androgens and cardiovascular disease.

Authors:  Peter Y Liu; Alison K Death; David J Handelsman
Journal:  Endocr Rev       Date:  2003-06       Impact factor: 19.871

8.  Vascular reactivity is impaired in genetic females taking high-dose androgens.

Authors:  R J McCredie; J A McCrohon; L Turner; K A Griffiths; D J Handelsman; D S Celermajer
Journal:  J Am Coll Cardiol       Date:  1998-11       Impact factor: 24.094

9.  Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population.

Authors:  D J Lerner; W B Kannel
Journal:  Am Heart J       Date:  1986-02       Impact factor: 4.749

10.  Testosterone relaxes rabbit coronary arteries and aorta.

Authors:  P Yue; K Chatterjee; C Beale; P A Poole-Wilson; P Collins
Journal:  Circulation       Date:  1995-02-15       Impact factor: 29.690

View more
  1 in total

1.  Cardiovascular Toxicity With Cisplatin in Patients With Testicular Cancer: Looking for Something Heavier Than Heavy Metal.

Authors:  Joerg Herrmann
Journal:  JACC CardioOncol       Date:  2020-09-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.